"Participants from both the biosimilar's and innovator's industry challenging each other on the underlying challenges of acceptability of biosimilars by stakeholders."
Pascal Fantauzzi, Merck Serono
The 4th annual World Biosimilar Congress is the region’s most targeted market place for biosimilar and biobetter stakeholders: an exhibition, a strategic keynote conference and real life case studies.
"It was a very informative event with lots of good topics and speakers."
Kai Li Loh, Duopharma
"It is an excellent meeting for getting updates and it is very relevant to the current status of biosimilar development."
Niamh Kinsella, NDA Group
"Highly focussed meeting with most participants being open to sharing experiences and data."
Steve Megit, Immunocore Ltd
Last year at the World Drug Safety Congress Europe, Dr David Lewis, Global head of pharmacovigilance, Novartis, gave the presentation “Social media and mobile reporting: ...
The post Social media and mobile reporting: Impact on PV operations. appeared first on Total Biopharma.
This year (2015) marks the tenth anniversary for the Terrapinn World Stem Cells & Regenerative Medicine Congress, but the question in my wind is how ...
The post Guest Blog: The rock and roll years for regenerative medicine appeared first on Total Biopharma.
The World Generic Medicines Congress Europe organized by Health Network Communications brought together industry stakeholders, decision makers, and experts for two days of presentations and ...
The post Thomson Reuters press-release: World Generic Medicines Congress Europe appeared first on Total Biopharma.
Innovation and strategy for pharmaceutical, biotech and R&D